# DOBUTAMINE HYDROCHLORIDE
> **ANDA216131** · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2022-12-21
## Drug
- **FDA Application Number:** ANDA216131
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOBUTAMINE HYDROCHLORIDE
- **Generic name:** DOBUTAMINE
- **Active ingredients:** DOBUTAMINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SLATE RUN PHARMA
- **Manufacturer:** Slate Run Pharmaceuticals
- **First approval:** 2022-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216131)
---
*MORVS · CC0 1.0*